Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative TRVI - Trevi Therapeutics, Inc.
10.2 M
LAST VALUE
3.87%
2 YEAR CAGR
18.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR